STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.

Biotechnology

STORM Therapeutics

STORM Therapeutics' headquarters in Babraham, United Kingdom

Margaret Daniel

Helen Harrison

Marguerite Hutchinson

Giles Pergl-Wilson

Josefin-Beate Holz

Beth Thomas

Yaara Ofir-Rosenfeld

Michael Johnston

Elizabeth Anderson

Angela Shibu

Hakan Goker

John Haurum

Tony Kouzarides

Christopher O’Donnell

Sakae Asanuma

Tim Edwards

Paul Workman

Eric Miska

Wesley Blackaby

Thomas Carell

Thomas Cech

Mark Dawson

Paul Leeson

The Research and Development team at STORM Therapeutics focuses on innovating and optimizing small molecule inhibitors that target RNA-modifying enzymes for cancer treatment. This multidisciplinary team of scientists, including principal and senior scientists across various specialties, collaborates on drug discovery, preclinical research, and translational oncology to advance novel therapeutic candidates from concept to clinical evaluation. Their work is pivotal in leveraging RNA epigenetics to create effective cancer therapies.

Research and Development

The Executive Management team at STORM Therapeutics is responsible for providing strategic direction and oversight to drive the company’s mission in RNA epigenetics. Comprising key leadership roles, including the CEO, CFO, and various board members, the team focuses on decision-making that shapes research priorities, fosters partnerships, and ensures financial sustainability, all aimed at advancing innovative therapies for cancer treatment.

Executive Management

The Leadership Team at STORM Therapeutics is responsible for setting the strategic direction and vision of the company, overseeing its research and development efforts in RNA epigenetics. This team collaborates to drive innovation, guide financial and operational decisions, and ensure the successful progression of small molecule inhibitor candidates through clinical development for cancer treatment. Their collective expertise helps to navigate the biotechnology landscape and position the company for growth and impact.

Leadership Team

STORM Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Executive Management

Leadership Team

Offices

STORM Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Executive Management

Leadership Team

Offices

Related companies